Business
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
Ghent, Belgium, Jan. 27, 2026 (GLOBE NEWSWIRE) -- SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES PRESS RELEASEREGULATED INFORMATION 27 January 2026, 7:00 am CET Ghent, Belgium, 27 January 2026 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, announces today that, as a result of a subscription to new shares by GEM Global Yield LL
About this update from Sequana Medical N.v
[{"type":"image","alt":"Sequana Medical NV","displaySize":"","headline":null,"caption":"Sequana Medical NV","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":64,"url":"https://media.zenfs.com/en/globenewswire.com/eebd983759ebc3a966954513471e9960"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/I6pT.8uzi87Vh1qGIu6GAg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTkwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/eebd983759ebc3a966954513471e9960","width":300,"height":64}},"lazy":false},{"type":"text","content":"Ghent, Belgium, Jan. 27, 2026 (GLOBE NEWSWIRE) -- SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT","length":100,"tagName":"p"},{"type":"text","content":"AND NEW NUMBER OF SHARES","length":24,"tagName":"p"},{"type":"text","content":"PRESS RELEASEREGULATED INFORMATION","length":35,"tagName":"p"},{"type":"text","content":"27 January 2026, 7:00 am CET","length":28,"tagName":"p"},{"type":"text","content":"Ghent, Belgium, 27 January 2026 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, announces today that, as a result of a subscription to new shares by GEM Global Yield LLC SCS ("GEM"), the Company's share capital has increased on 26 January 2026 from EUR 7,592,593.85 to EUR 7,721,440.65 and the number of issued and outstanding shares has further increased from 73,284,239 to 74,527,934 ordinary shares, through the issuance of a total of 1,243,695 new shares at an issue price of (rounded) EUR 0.5665 per share to the benefit of GEM. The aforementioned capital increase has been completed in the framework of the settlement of a seventh subscription request notice issued by the Company to GEM under the share subscription facility agreement entered into on 17 March 2025 between a.o. the Company and GEM (the "Facility"), and which had been approved in principle by the Company's board of directors within the framework of the authorised capital on 8 April 2025. For more information about the Facility, reference is made to the Company's press release dated 18 March 2025 (which can be accessed here).","length":1297,"tagName":"p"},{"type":"text","content":"For more information about the aforementioned subscription to new shares by GEM and...